← Open Payments lookup

MARCI ISAAC: Open Payments

NPI 1811353915 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$728 in 31 payments from 13 companies in 2025. Trend: 2023 $918 · 2024 $865 · 2025 $728

Food & beverage: $728
CompanyPaymentsAmount
Amgen Inc.5$163
CVRx, Inc.6$136
E.R. Squibb & Sons, L.L.C.3$72
Novo Nordisk Inc3$64
Novartis Pharmaceuticals Corporation3$61
SCPHARMACEUTICALS INC.3$50
ABIOMED1$38
Boehringer Ingelheim Pharmaceuticals, Inc.2$36
Alnylam Pharmaceuticals Inc.1$31
Merck Sharp & Dohme LLC1$22

Products named: REPATHA, Barostim Neo System, CAMZYOS, FUROSCIX, Ozempic, LEQVIO, JARDIANCE, AMVUTTRA.

Industry payments across TX — which companies pay providers there.